SEP 15·SEC EDGARLow
TANNENBAUM LEONARD M purchased $141K of AFCG
TANNENBAUM LEONARD M purchased 40,198 shares of Advanced Flower Capital Inc. (AFCG) at an average of $3.52 ($3.50–$3.55, $0.14M total) across 2 trades over 2026-09-11 to 2026-09-14.
StockNASDAQ · US · USDFinancial Services · Asset Management
$AFCG
Advanced Flower Capital Inc.
Price · $AFCGvia TradingView
AI sentiment · 7d0 articles
No enriched coverage for $AFCG in the last 7 days.
Insider · 30dAll trades →
- Buys
- $1.3M 13 txs
- Sells
- — 0 txs
TANNENBAUM LEONARD M13× · $1.3M
10b5-1 share of filings0%
Top stories · $AFCGMore →
SEP 11·SEC EDGAR
TANNENBAUM LEONARD M purchased $121K of AFCG
TANNENBAUM LEONARD M purchased 35,000 shares of Advanced Flower Capital Inc. (AFCG) at $3.46 ($0.12M total) on 2026-09-10.
SEP 4·SEC EDGAR
TANNENBAUM LEONARD M purchased $55K of AFCG
TANNENBAUM LEONARD M purchased 15,223 shares of Advanced Flower Capital Inc. (AFCG) at $3.59 on 2026-09-02.
AFCG sentiment & insider activity
Recent AFCG coverage spans insider activity, earnings and financial news.
In the last 30 days, AFCG insiders filed 13 SEC Form 4 transactions — 13 purchases ($1.3M) and no sales. The most active reporter was TANNENBAUM LEONARD M with 13 filings.
What's driving AFCG
Insider purchase suggests confidence in Advanced Flower Capital's prospects.
Small insider purchase by a director; unlikely to move the stock significantly.
Insider buying may signal confidence but the transaction size is modest relative to market cap.
Significant insider buying may signal confidence, potentially supporting short-term price upside.
Insider buying may signal confidence, but the amount is modest relative to holdings.
AlphAI scores every news story that mentions AFCG with an AI model for sentiment and relevance, and aggregates insider trades from Advanced Flower Capital Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
News on $AFCG
Score
TANNENBAUM LEONARD M purchased $141K of AFCG
TANNENBAUM LEONARD M purchased 40,198 shares of Advanced Flower Capital Inc. (AFCG) at an average of $3.52 ($3.50–$3.55, $0.14M total) across 2 trades over 2026-09-11 to 2026-09-14.
1 min readTANNENBAUM LEONARD M purchased $121K of AFCG
TANNENBAUM LEONARD M purchased 35,000 shares of Advanced Flower Capital Inc. (AFCG) at $3.46 ($0.12M total) on 2026-09-10.
1 min readTANNENBAUM LEONARD M purchased $55K of AFCG
TANNENBAUM LEONARD M purchased 15,223 shares of Advanced Flower Capital Inc. (AFCG) at $3.59 on 2026-09-02.
1 min readTANNENBAUM LEONARD M purchased $424K of AFCG
TANNENBAUM LEONARD M purchased 119,025 shares of Advanced Flower Capital Inc. (AFCG) at an average of $3.56 ($3.53–$3.60, $0.42M total) across 2 trades over 2026-08-28 to 2026-08-31.
1 min readTANNENBAUM LEONARD M purchased $119K of AFCG
TANNENBAUM LEONARD M purchased 34,606 shares of Advanced Flower Capital Inc. (AFCG) at an average of $3.43 ($3.41–$3.46, $0.12M total) across 2 trades over 2026-08-26 to 2026-08-27.
1 min readTANNENBAUM LEONARD M purchased $204K of AFCG
TANNENBAUM LEONARD M purchased 60,000 shares of Advanced Flower Capital Inc. (AFCG) at an average of $3.40 ($3.40–$3.41, $0.20M total) across 2 trades over 2026-08-24 to 2026-08-25.
3 min readTANNENBAUM LEONARD M purchased $82K of AFCG
TANNENBAUM LEONARD M purchased 25,000 shares of Advanced Flower Capital Inc. (AFCG) at $3.28 on 2026-08-21.
1 min readTANNENBAUM LEONARD M purchased $66K of AFCG
TANNENBAUM LEONARD M purchased 20,000 shares of Advanced Flower Capital Inc. (AFCG) at $3.29 on 2026-08-20.
1 min read
Advanced Flower Capital (AFCG) Q2 2026 Earnings Call Transcript
Advanced Flower Capital (AFCG) reported Q2 2026 net investment income of $3.5M, or $0.15 per share, with NAV per share rising to $8.25. The company repurchased 839,406 shares and has a $1.3B investment pipeline. Management highlighted rising default rates in private credit and challenges in the cannabis industry. AFCG is resolving nonaccrual loans and focusing on lower middle market borrowers.
3 min readWednesday’s insider activity: Major buys and sells disclosed
On Wednesday, notable insider trading activity occurred in U.S. stocks. Zentalis Pharmaceuticals (ZLAB) saw a major purchase by Walters Group, while Bakkt (BKKT), Universal Safety Products (UNSP), Advanced Flower Capital (AFCG), and Brilliant Earth (BID) also had significant insider buys. Astera Labs (ALAB), Adaptive Biotechnologies (ADPT), and PACS Group (PACS) reported insider sales, some mandatory for tax purposes. InvestingPro analysis suggests some stocks are undervalued or overvalued.
3 min read